Breakthrough T1D Heads, Virtually, to ADA’s 80th Scientific Sessions
The American Diabetes Association’s (ADA) 80th Scientific Sessions is almost here! From June 12-16, scientists and healthcare professionals will gather,…
Medtronic Panel Discusses Supporting T1D Community During COVID-19
During a recent Breakthrough T1D Facebook Live event, a panel of leaders discussed Medtronic’s efforts to support the T1D community…
Meet the Scientist: Local Immune Suppression with a Novel Protein
Mark Poznansky, M.D., Ph.D., wants the seemingly impossible—a person with type 1 diabetes (T1D) has a procedure where beta cells…
Improving the Lives of Veterans With Diabetes
How to access the latest diabetes management tools through the Department of Veterans Affairs with Armed For Diabetes .
Public and Private Organizations, All with the Same Goal: End T1D
In this time of great uncertainty, there is some exciting news out of Europe. Innodia, a partnership between public and…
Insulin Contains the Expected Quantity of Active Insulin
Credit: Diabetes Care In December 2017, the type 1 diabetes (T1D) community got a jolt, when a publication, testing the…
A Promising (Preclinical) Vaccine for Type 1 Diabetes
Wouldn’t it be nice if you could take a vaccine in infancy, and type 1 diabetes would not develop? Preclinical…
Dr. Carla Greenbaum Talks about T1D TrialNet During the COVID-19 Pandemic
Carla Greenbaum, M.D., chair of TrialNet—an international Breakthrough T1D-supported network that is dedicated to finding cures for type 1 diabetes…
Breakthrough T1D Plays a Leadership Role, Again, to Marshal Resources for T1D Research
It’s 2004. The California Institute for Regenerative Medicine (CIRM), which will fund $3 billion in stem cell research to advances…
At the Front Lines in COVID-19: Breakthrough T1D-Funded Scientist’s Company Developing a Vaccine
With coronavirus closing schools and forcing so many people to stay inside or wear facemasks every time they step outdoors,…
